{"id":"NCT02710890","sponsor":"UCB BIOSCIENCES, Inc.","briefTitle":"Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.","officialTitle":"A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide in Children (>= 1 Month to < 17 Years of Age) With Epilepsy","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-05-30","primaryCompletion":"2019-06-28","completion":"2019-06-28","firstPosted":"2016-03-17","resultsPosted":"2020-07-15","lastUpdate":"2023-02-23"},"enrollment":103,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"Lacosamide","otherNames":["Vimpat"]}],"arms":[{"label":"Lacosamide","type":"EXPERIMENTAL"}],"summary":"EP0060 is a multicenter, open-label study to evaluate the safety and tolerability of intravenous (iv) Lacosamide (LCM) in pediatric subjects \\>= 1 month to \\< 17 years of age with epilepsy.","primaryOutcome":{"measure":"Percentage of Participants With at Least One Adverse Event Reported Spontaneously by the Participant/or Caregiver (Including Parent/Legal Guardian) or Observed by the Investigator During the Study","timeFrame":"From Screening Period (Day -7 to Day -1) up to the End-of-Study Period (up to Day 37)","effectByArm":[{"arm":"Lacosamide Age Cohort ≥ 1 Month - < 8 Years (SS-iv)","deltaMin":12.5,"sd":null},{"arm":"Lacosamide Age Cohort ≥ 8 - < 17 Years (SS-iv)","deltaMin":14.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":15},"locations":{"siteCount":23,"countries":["United States","Hungary","Italy","Poland","Ukraine"]},"refs":{"pmids":["36529709"],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":48},"commonTop":["Blood triglycerides increased","Functional gastrointestinal disorder","Pyrexia","Respiratory tract infection","Respiratory tract infection viral"]}}